✦ LIBER ✦

Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas: a clinical efficacy trial

✍ Scribed by A Taliansky-Aronov; F Bokstein; I Lavon; T Siegal

Book ID: 106480431
Publisher: Springer US
Year: 2006
Tongue: English
Weight: 266 KB
Volume: 79
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-005-9020-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose-Dense Temozolomide for Newly Diagno

Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

✍ Gilbert, M. R.; Wang, M.; Aldape, K. D.; Stupp, R.; Hegi, M. E.; Jaeckle, K. A.; 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 176 KB

A phase II study of intensified chemothe

A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis

✍ Nimish A. Mohile; Peter Forsyth; Douglas Stewart; Jeffrey J. Raizer; Nina Paleol 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 232 KB

Efficacy and biomarker findings from AVa

Efficacy and biomarker findings from AVaglio, a phase III trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma

✍ Wick, W.; Cloughesy, T.; Mason, W.; Henriksson, R.; Saran, F.; Nishikawa, R.; Hi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Phase 2 Trial of Temozolomide Plus Bevac

Phase 2 Trial of Temozolomide Plus Bevacizumab, Lithium, and Radiation Treatment for Newly Diagnosed High-Grade Gliomas: Interim Analysis

✍ Tam, M.; Gruber, M.; Gruber, D.; Golfinos, J.; Parker, E.; Zagzag, D.; Narayana, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Phase II study of neoadjuvant 1, 3-bis (

Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma : A North American Brain Tumor Consortium trial

✍ Susan M. Chang; Michael D. Prados; W. K. Alfred Yung; Howard Fine; Larry Junck; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract ## BACKGROUND Temozolomide (TMZ) and 1, 3‐bis (2‐chloroethyl)‐1‐nitrosourea (BCNU) are reported to be active agents in anaplastic glioma (AG). TMZ has also been shown to deplete alkyltransferase, a DNA repair enzyme that contributes to nitrosourea resistance. The objective of the curre

A Phase I Trial of Tipifarnib With Radia

A Phase I Trial of Tipifarnib With Radiation Therapy, With and Without Temozolomide, for Patients With Newly Diagnosed Glioblastoma

✍ Phioanh Leia Nghiemphu; Patrick Y. Wen; Kathleen R. Lamborn; Jan Drappatz; H. Ia 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 178 KB